Zhang, YL, Tedeschi, SK, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, JA, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, Diaz-Torne, C, Mccarthy, GM, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Coronel, L, Stamp, LK, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, Fitzgerald, J, Dalbeth, N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 72DOI:10.1016/j.semarthrit.2025.152669. PMID:40086154. IF:4.400(Q1/1D).

Martinez-Molina, C, Park, HS, Díaz-Torné, C, Vidal, S, Corominas, H. FACTORS ASSOCIATED WITH ACHIEVING REMISSION OR LOW DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING JANUS KINASE INHIBITOR TREATMENT. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3700. PMID:. IF:20.600(Q1/1D).

Azuaga, AB, Cuervo, A, Reina, D, Estrada, P, Soria, LM, Aparicio, M, Moreno, M, Arevalo, M, Laiz, A, Moya, P, Alascio, L, Riera, J, Scher, JU, Crespillo, JDDC, Ramirez, J. CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1990. PMID:. IF:20.600(Q1/1D).

Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellví, I, Alvarez, ED. EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1643. PMID:. IF:20.600(Q1/1D).